Clinical Issues in the Surgical Management of Screen-Identified Lung Cancers.


The National Lung Screening Trial reported a 20% reduction in lung cancer-specific mortality in patients screened with low-dose computed tomography (CT) compared with those screened by plain chest radiography. This led to the endorsement of CT screening for lung cancer by the US Preventive Services Task Force and the subsequent approval of screening as a preventive health service reimbursable by the Centers for Medicare and Medicaid Services. This review outlines the diagnostic and therapeutic challenges associated with the increased number of screen-identified indeterminate lung nodules, highlighting currently recommended follow-up and management algorithms, as well as the various methods of nodule localization, tissue diagnosis, and definitive local therapeutic modalities.

Cite this paper

@article{Kamel2015ClinicalII, title={Clinical Issues in the Surgical Management of Screen-Identified Lung Cancers.}, author={Mohamed K Kamel and Brendon M. Stiles and Nasser Khaled Altorki}, journal={Oncology}, year={2015}, volume={29 12}, pages={944-9, 951} }